KRMD

Repro Med Systems Inc

KRMD, USA

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

https://www.korumedical.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
KRMD
stock
KRMD

Forecast Cut: What Wall Street predicts for KRMD stock price - 2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers moha.gov.vn

Read more →
KRMD
stock
KRMD

Alto Ingredients And 2 Other Penny Stocks To Watch Closely simplywall.st

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$5.5625

Analyst Picks

Strong Buy

4

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

16.23

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.73 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.87 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.12 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Medium

0.65

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 49.44% of the total shares of Repro Med Systems Inc

1.

First Light Asset Management, LLC

(10.1257%)

since

2025/06/30

2.

Topline Capital Management LLC

(7.8044%)

since

2025/06/30

3.

Vanguard Group Inc

(4.511%)

since

2025/06/30

4.

BlackRock Inc

(4.0681%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(2.3604%)

since

2025/07/31

6.

Geode Capital Management, LLC

(2.1567%)

since

2025/06/30

7.

Meros Investment Management, LP

(1.8393%)

since

2025/06/30

8.

Archon Capital Management LLC

(1.5143%)

since

2025/06/30

9.

iShares Russell 2000 ETF

(1.4706%)

since

2025/08/31

10.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9935%)

since

2025/07/31

11.

Fidelity Small Cap Index

(0.9178%)

since

2025/06/30

12.

Acuitas Investments, LLC

(0.8705%)

since

2025/06/30

13.

State Street Corp

(0.8527%)

since

2025/06/30

14.

iShares Russell 2000 Growth ETF

(0.8118%)

since

2025/08/31

15.

RBF LLC

(0.773%)

since

2025/06/30

16.

Albion Financial Group (Utah)

(0.7708%)

since

2025/06/30

17.

Northern Trust Corp

(0.7009%)

since

2025/06/30

18.

Morgan Stanley - Brokerage Accounts

(0.6485%)

since

2025/06/30

19.

Calamos Timpani Small Cap Growth I

(0.5233%)

since

2025/07/31

20.

Timpani Small Cap Growth Equity

(0.5079%)

since

2025/06/30

21.

Fidelity Extended Market Index

(0.5041%)

since

2025/07/31

22.

White Pine Capital LLC

(0.4876%)

since

2025/06/30

23.

Vanguard Russell 2000 ETF

(0.4395%)

since

2025/07/31

24.

SEI Tax-Managed Small/Mid Cap F (SIMT)

(0.3824%)

since

2025/08/31

25.

Acadian Asset Management LLC

(0.3336%)

since

2025/06/30

26.

State St Russell Sm Cap® Indx SL Cl I

(0.3242%)

since

2025/08/31

27.

Charles Schwab Investment Management Inc

(0.2576%)

since

2025/06/30

28.

Squarepoint Ops LLC

(0.235%)

since

2025/06/30

29.

Schwab Small Cap Index

(0.2299%)

since

2025/07/31

30.

Renaissance Technologies Corp

(0.2262%)

since

2025/06/30

31.

NT R2000 Index Fund - NL

(0.2219%)

since

2025/06/30

32.

PNC Financial Services Group Inc

(0.2098%)

since

2025/06/30

33.

iShares Micro-Cap ETF

(0.2085%)

since

2025/08/31

34.

Goldman Sachs Group Inc

(0.1962%)

since

2025/06/30

35.

Fidelity Total Market Index

(0.1829%)

since

2025/07/31

36.

NT R2000 Index Fund - DC - NL - 3

(0.1769%)

since

2025/06/30

37.

Extended Equity Market Fund K

(0.1719%)

since

2025/06/30

38.

iShares Russell 2000 Small-Cap Idx Instl

(0.1591%)

since

2025/07/31

39.

Acuitas US Microcap Institutional

(0.1388%)

since

2025/06/30

40.

Russell 2500â„¢ Index Fund F

(0.1368%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.0171

Latest Release

Date

2025-09-30

EPS Actual

-0.0168

EPS Estimate

-0.0223

EPS Difference

0.0055

Surprise Percent

24.6637%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(2.5)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(4)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.